EA200800162A1 - Новые фармацевтические композиции с замедленным высвобождением и способы их получения - Google Patents
Новые фармацевтические композиции с замедленным высвобождением и способы их полученияInfo
- Publication number
- EA200800162A1 EA200800162A1 EA200800162A EA200800162A EA200800162A1 EA 200800162 A1 EA200800162 A1 EA 200800162A1 EA 200800162 A EA200800162 A EA 200800162A EA 200800162 A EA200800162 A EA 200800162A EA 200800162 A1 EA200800162 A1 EA 200800162A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- preparation
- methods
- pharmaceutical compositions
- new pharmaceutical
- active agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Новая фармацевтическая композиция с замедленным высвобождением, включающая по крайней мере один активный агент(ы), или его таутомерные формы, аналоги, изомеры, полиморфы, сольваты или их соли; предпочтительно используется противовирусный активный агент. Также предлагается способ получения такой композиции и способ ее применения. Композиции с замедленным высвобождением настоящего изобретения способны доставлять активный агент желательным образом в течение продолжительного периода времени.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1680DE2005 | 2005-06-29 | ||
PCT/IN2006/000225 WO2007000779A2 (en) | 2005-06-29 | 2006-06-29 | Pharmaceutical sustained release compositions and processes thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200800162A1 true EA200800162A1 (ru) | 2008-06-30 |
Family
ID=37027780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200800162A EA200800162A1 (ru) | 2005-06-29 | 2006-06-29 | Новые фармацевтические композиции с замедленным высвобождением и способы их получения |
Country Status (15)
Country | Link |
---|---|
US (1) | US20090099154A1 (ru) |
EP (1) | EP1912628A2 (ru) |
JP (1) | JP2009500318A (ru) |
CN (1) | CN101212957A (ru) |
AR (1) | AR055070A1 (ru) |
AU (1) | AU2006263338A1 (ru) |
BR (1) | BRPI0613070A2 (ru) |
CA (1) | CA2613407A1 (ru) |
CR (1) | CR9705A (ru) |
EA (1) | EA200800162A1 (ru) |
MX (1) | MX2008000084A (ru) |
NO (1) | NO20080399L (ru) |
RS (1) | RS20070512A (ru) |
TN (1) | TNSN07490A1 (ru) |
WO (1) | WO2007000779A2 (ru) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0709606B8 (pt) | 2006-03-16 | 2021-05-25 | Tris Pharma Inc | suspensão líquida administrável oralmente com características de liberação modificada |
CN101489937B (zh) * | 2006-06-08 | 2016-08-10 | 耶鲁大学 | 用于渗透性溶质回收的多级塔蒸馏(mscd)方法 |
JP5547966B2 (ja) * | 2006-12-15 | 2014-07-16 | カンピナ ネーデルランド ホールディング ビー.ブイ. | 持続放出用の賦形剤及びその使用 |
EP1935411A1 (en) | 2006-12-15 | 2008-06-25 | Campina Nederland Holding B.V. | Slow release excipient and its use |
US20100056493A1 (en) * | 2007-01-25 | 2010-03-04 | Rajesh Jain | Modified release pharmaceutical composition and a process of making the same |
EP2155169B1 (en) | 2007-06-08 | 2016-03-23 | Boehringer Ingelheim International GmbH | Extended release formulation of nevirapine |
CA2702904A1 (en) | 2007-10-19 | 2009-04-23 | Otsuka Pharmaceutical Co., Ltd. | Matrix-type pharmaceutical solid preparation |
WO2010026467A2 (en) * | 2008-09-04 | 2010-03-11 | Torrent Pharmaceuticals Ltd. | Controlled release dosage form of high solubility active ingredient |
BR112012019374B1 (pt) * | 2010-02-03 | 2022-01-11 | Pharma Two B Ltd | Composição farmacêutica oral e uso de um agente ativo para a preparação de uma composição farmacêutica oral para o tratamento de doenças neurodegenerativas |
WO2011117875A1 (en) * | 2010-03-26 | 2011-09-29 | Hetero Research Foundation | Salts of fluvastatin and process for the preparation of substantially amorphous fluvastatin sodium |
KR20120055313A (ko) * | 2010-11-23 | 2012-05-31 | 주식회사 바이오파마티스 | 레베티라세탐 또는 이의 약학적으로 허용되는 염을 포함하는 용출 안정성이 개선된 서방형 약학 조성물 및 이의 제조방법 |
CN102058553B (zh) * | 2010-12-28 | 2012-10-10 | 哈药集团三精制药股份有限公司 | 阿昔洛韦缓释片及其制备方法 |
JP5976657B2 (ja) * | 2011-09-30 | 2016-08-24 | 持田製薬株式会社 | 易服用性固形製剤 |
FR2983409B1 (fr) * | 2011-12-06 | 2013-12-27 | Ethypharm Sa | Comprime susceptible de lutter contre le detournement par voie injectable |
JP2013119540A (ja) * | 2011-12-08 | 2013-06-17 | Nipro Corp | 固形医薬組成物およびその製造法 |
AU2013235345B2 (en) | 2012-03-21 | 2016-03-24 | Galleon Labs Llc | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation |
WO2014181390A1 (ja) * | 2013-05-08 | 2014-11-13 | 全星薬品工業株式会社 | 機能性高分子皮膜で被覆された高含量薬物粒子およびそれを含む錠剤ならびにそれらの製造方法 |
CN105611915B (zh) * | 2013-08-14 | 2021-05-11 | 赢创运营有限公司 | 包衣组合物 |
WO2015048153A1 (en) * | 2013-09-24 | 2015-04-02 | Cosmederm Bioscience, Inc. | Strontium-containing complexes for treating gastroesophageal reflux and barrett's esophagus |
CN103705933A (zh) * | 2013-12-18 | 2014-04-09 | 北京科源创欣科技有限公司 | 奥卡西平药物组合物及制备方法 |
JP6532765B2 (ja) * | 2014-06-06 | 2019-06-19 | 株式会社ファンケル | 即効性成分と持続性成分を含む錠剤 |
PL3223797T3 (pl) | 2014-11-26 | 2020-07-27 | Evonik Operations Gmbh | Kompozycja farmaceutyczna lub nutraceutyczna wykazująca odporność na wpływ etanolu |
CN104666267B (zh) * | 2015-03-27 | 2017-08-08 | 康普药业股份有限公司 | 一种阿昔洛韦药物组合物 |
US11235002B2 (en) | 2015-08-21 | 2022-02-01 | Galleon Labs Llc | Strontium based compositions and formulations for pain, pruritus, and inflammation |
US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
JP6326114B2 (ja) * | 2016-11-01 | 2018-05-16 | エルメッド エーザイ株式会社 | レベチラセタム含有医薬組成物及びその製造方法、並びにレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止方法、及びレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止剤 |
CN106943356B (zh) * | 2017-05-10 | 2019-11-08 | 武汉人福药业有限责任公司 | 一种泛昔洛韦缓释颗粒剂及其制备方法 |
JP6958856B2 (ja) * | 2017-08-09 | 2021-11-02 | 日本臓器製薬株式会社 | 錠剤 |
US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
CN109466152B (zh) * | 2018-09-04 | 2021-01-26 | 浙江罗奇泰克科技股份有限公司 | 一种高导热铁基板的制作方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY110880A (en) * | 1991-01-30 | 1999-06-30 | The Wellcome Foundation Ltd | Water-dispersible tablets |
US5455046A (en) * | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US5695781A (en) * | 1995-03-01 | 1997-12-09 | Hallmark Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers |
US20030134864A1 (en) * | 1996-02-07 | 2003-07-17 | Smithkline Beecham P.L.C. | Activity of penciclovir against epstein-barr virus |
IT1282650B1 (it) * | 1996-02-19 | 1998-03-31 | Jagotec Ag | Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici |
NZ510487A (en) * | 1998-09-14 | 2003-04-29 | Ranbaxy Lab Ltd | Pharmaceutical composition comprising ciprofloxacin, sodium alginate, xanthan gum and a cross-linker polymer in a tablet or capsule form |
WO2002102415A1 (en) * | 2001-06-18 | 2002-12-27 | Blue Cross Laboratories Limited | Gastric floating system |
US20060159752A1 (en) * | 2002-08-14 | 2006-07-20 | Jain Girish K | Extended release matrix tablets |
US20050112198A1 (en) * | 2003-10-27 | 2005-05-26 | Challapalli Prasad V. | Bupropion formulation for sustained delivery |
-
2006
- 2006-06-29 US US11/922,960 patent/US20090099154A1/en not_active Abandoned
- 2006-06-29 AR ARP060102820A patent/AR055070A1/es not_active Application Discontinuation
- 2006-06-29 CN CNA2006800239073A patent/CN101212957A/zh active Pending
- 2006-06-29 BR BRPI0613070-4A patent/BRPI0613070A2/pt not_active IP Right Cessation
- 2006-06-29 MX MX2008000084A patent/MX2008000084A/es unknown
- 2006-06-29 EA EA200800162A patent/EA200800162A1/ru unknown
- 2006-06-29 EP EP06766278A patent/EP1912628A2/en not_active Withdrawn
- 2006-06-29 RS RSP-2007/0512A patent/RS20070512A/sr unknown
- 2006-06-29 WO PCT/IN2006/000225 patent/WO2007000779A2/en active Search and Examination
- 2006-06-29 JP JP2008519142A patent/JP2009500318A/ja not_active Withdrawn
- 2006-06-29 CA CA002613407A patent/CA2613407A1/en not_active Abandoned
- 2006-06-29 AU AU2006263338A patent/AU2006263338A1/en not_active Abandoned
-
2007
- 2007-12-28 TN TNP2007000490A patent/TNSN07490A1/en unknown
-
2008
- 2008-01-21 NO NO20080399A patent/NO20080399L/no not_active Application Discontinuation
- 2008-01-29 CR CR9705A patent/CR9705A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20080399L (no) | 2008-03-31 |
AU2006263338A1 (en) | 2007-01-04 |
CA2613407A1 (en) | 2007-01-04 |
CR9705A (es) | 2008-10-30 |
TNSN07490A1 (en) | 2009-03-17 |
US20090099154A1 (en) | 2009-04-16 |
BRPI0613070A2 (pt) | 2010-12-21 |
MX2008000084A (es) | 2008-03-18 |
EP1912628A2 (en) | 2008-04-23 |
JP2009500318A (ja) | 2009-01-08 |
WO2007000779A2 (en) | 2007-01-04 |
WO2007000779A3 (en) | 2007-06-28 |
AU2006263338A2 (en) | 2008-06-05 |
AR055070A1 (es) | 2007-08-01 |
RS20070512A (en) | 2009-01-22 |
CN101212957A (zh) | 2008-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200800162A1 (ru) | Новые фармацевтические композиции с замедленным высвобождением и способы их получения | |
CY1120994T1 (el) | Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων | |
BRPI0509074A (pt) | composições farmacêuticas compreendendo agonistas do receptor da tiróide | |
DK1856090T3 (da) | Substituerede thiophen-derivater som glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser | |
GT200500309A (es) | Derivados de sulfonilbencilimidazol | |
ATE485269T1 (de) | C-verknüpfte zyklische antagonisten des p2y1- rezeptors mit eignung bei der behandlung thrombotischer leiden | |
MA29136B1 (fr) | Agents de potentialisation de recepteurs du glutamate | |
DK1957484T3 (da) | Glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser | |
RU2011138962A (ru) | Производные 4-изопропилфенилглюцита в качестве ингибиторов sglt1 | |
CL2007002867A1 (es) | Compuestos derivados de 2-(bencimidazolil)purina, inhibidores de janus quinasa 3; composicion farmaceutica que los contiene; y su uso para tratar enfermedades autoinmune, inflamatorias, cardiovasculares, rechazo de implante, entre otras. | |
MA29088B1 (fr) | Composes d'indazole-carboxamide. | |
AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
NO20061981L (no) | Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist | |
EA200970532A1 (ru) | Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола | |
UA96277C2 (en) | Benzimidazole derivatives | |
PA8623101A1 (es) | Compuestos farmaceuticamente activos | |
DE602006018713D1 (de) | Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate | |
DK1951659T3 (da) | Glucagonreceptorantagonister, fremstilling og terapeutisk anvendelse heraf | |
SV2009003212A (es) | Inhibidores de metaloproteasa derivados de heterociclicos ref. prd2727svpct | |
GEP20104880B (en) | Carboxamide derivatives as muscarinic receptor antagonists | |
SE0403171D0 (sv) | New compounds | |
BRPI0417810B8 (pt) | arilpirazóis substituídos como agentes parasiticidas, composição veterinária e uso dos mesmos | |
CY1109694T1 (el) | Παραγωγα πυρρολιδινης ως ανταγωνιστες υποδοχεα η3 ισταμινης | |
CL2007000789A1 (es) | Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer. | |
MX2007005525A (es) | Tratamiento terapeutico de resorcion ose acelerada. |